what is the mechanism of action of glp-1 agonists - it? GLP-1: Actions on Beta-cell Mass
Description
These results are unprecedented in the field of obesity medicine, rivaling the outcomes of some bariatric surgeries
S.XanthakisV
For those initiating GLP-1 therapy in 2021, 33% were persistent, while in the first quarter of 2024, 63% of new initiators were persistent
The ability of probenecid to inhibit cAMP accumulation in GLP-1(2836)treated human caECs further supports our finding that GLP-1(2836) works through sAC to increase intracellular cAMP levels (Supplemental Figure 8C)
